Minimally Invasive Spine Surgery Market - Forecast(2024 - 2030)
Minimally Invasive Spine Surgery Market Overview
The Minimally Invasive Spine Surgery Market size is estimated to reach $635.2 million by 2027. Furthermore, it is poised to grow at a CAGR of 5.1% over the forecast period of 2022-2027. Minimal invasive surgeries are extensively growing globally owing to the various benefits it offers. It works by making small incisions near the spine, which also minimizes the damage around the muscles and ligaments. Further, it offers faster recovery times, reduces chances of catching a secondary infection, low blood loss, and lastly allowing the patient to return back to their lifestyle. The minimally invasive surgeries differ from open-spine surgery in multiple ways. For one, to perform an open-spine surgery, the surgeon will make an incision around 6 inches. Moreover, the surgical times are longer than discussed and the patient must remain hospitalized for a longer period of time. Various surgeries are now being performed across the globe to cater to the fuelling needs of the patients afflicted. For example, anterior cervical discectomy and fusion are performed to treat disc herniation and degenerative disc diseases. Owing to the rising cases of trauma supplemented by the awareness pertaining to the advantages the surgeries offer are some of the identified drivers for the Minimally Invasive Spine Surgery Industry for the projected period of 2022-2027.
Report Coverage
The report: “Minimally
Invasive Spine Surgery Market Forecast
(2022-2027)", by
Industry ARC covers an in-depth analysis of the following segments of the Minimally
Invasive Spine Surgery Market.
By Treatment – Compression Fracture
Repair, Spinal Stenosis Decompression, Herniated Disc Removal, Spinal
Canal Enlargement, Minimally Invasive Spinal Fusion,
and Artificial Disc Replacement.
By Instruments- Implants & Instrumentation and
Biomaterials.
By End-Users- Hospitals, Private Clinics, Ambulatory
Surgical Centers, and Others.
By
Geography- North America (U.S., Canada, Mexico), Europe (Germany,
United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia
Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest
of Asia Pacific), South America (Brazil, Argentina, and Rest of South America),
and Rest of the World (the Middle East, and Africa).
Key Takeaways
- Geographically, North America’s minimally invasive spine surgery market held the dominant market share in the year 2021. It is owing to the prevalence of spine diseases amongst all age groups. Moreover, ease of treatment, reimbursement policies, and knowledgeable medical professionals are some of the factors for the soaring market. However, Asia-Pacific is set to outgrow other regions, and offer lucrative growth opportunities to the marketers. It is owing to the rising focus pertaining to the development of medical infrastructure and medical tourism.
- The uprising of ASCs and the growing geriatric population are some of the key drivers for the market. However, insurance claims for elective spine surgery remain vulnerable and pose an active market challenge.
- A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Minimally Invasive Spine Surgery Market Report.
Minimally Invasive Spine Surgery Market- Geography (%) for 2021.
For More Details on This Report - Request for Sample
Minimally Invasive Spine Surgery
Market Segmentation Analysis- By Treatment
The minimally invasive spine surgery market is further
bifurcated into Compression Fracture
Repair, Spinal Stenosis Decompression, Herniated Disc Removal, Spinal Canal
Enlargement, Minimally Invasive Spinal Fusion, and Artificial Disc Replacement.
Herniated Disc Removal held a dominant market share in the year 2021. The
following condition arrives when the patient experiences compressed nerves.
Further, laminectomies are performed in conjunction with discectomy. Further,
around 70-80% of the patients feel relief in their back-pain, which makes the
following problem curable.
However, Spinal
Stenosis Decompression is estimated to be the fastest-growing, with a CAGR of
5.7% over the forecast period of 2022-2027. It happens when one’s spinal canal
narrows down and starts creating bone spurs and obstructions. Further, the
American Academy of Orthopedic Surgery estimates that nearly 8-11% of the
population in the US have such ailment. Moreover, they estimate that in 2021,
the numbers were added by at-least 2.5 million. Owing to the following factors, the
segment is estimated to offer a steadfast pace to marketers.
Minimally Invasive Spine Surgery Market Segmentation Analysis- By End-Users
The minimally invasive spine surgery market based on
end-users can be further segmented into Hospitals, Private Clinics, Ambulatory
Surgical Centers, and Others. Ambulatory Surgical Centers held a dominant
market share in the year 2021. It is owing to the options patients have in
terms of minimally invasive surgeries. Moreover, hospitals outsource such
surgeries to outpatient centers or ambulatory surgical centers. Since the
incisions are small and the bleeding or complications are low, ambulatory surgical
centers are able to provide services at a higher satisfaction rate.
Moreover, Ambulatory Surgical Centers are estimated to be
the fastest-growing, with a CAGR of 5.9% over the forecast period of 2022-2027.
It is owing to the government’s preference, as the following module saves billions
of dollars. Additionally, as of 2010, there were close to 5000 ASC, which have
now grown to 9600 in 2021. Hence, the substantial addition of such centers
would allow the segment to grow.
Minimally Invasive Spine Surgery Market Segmentation Analysis- By Geography
The minimally invasive spine surgery market based on
geography can be further segmented into North America, South America, Europe,
Asia-Pacific, and the Rest of the World. Geographically, North America’s market
held a dominant share of 35% in 2021. It is owing to the increment in the
number of ASCs along with the constant rise in the cases of spine injuries. Also, the geriatric population is
substantially growing. For example, by the year 2025, Canada and the USA will have
age dependency close to 30% for the age group of 60 and above.
However,
Asia-Pacific is poised to offer lucrative growth opportunities to marketers
in the projected period of 2022-2027. It is predominantly linked to the growing
geriatric population and sedentary lifestyles. For example, there has been a
decrement in the fertility rates of the low-and middle-income countries of the
Asia-Pacific, which thereby will increase the older generation, and hence the market
will be substantially benefitted.
Minimally Invasive Spine Surgery Market Drivers
The operational advantages over the traditional surgeries have aided the market
The operational advantages of minimally invasive surgeries are many and have countered and answered to all the potential drawbacks of extensive and traditional surgeries. Post-operative hematoma formation, neurological diseases, and disabilities, along with problems pertaining to wound healing, were found in the majority. To counter such problems, minimally invasive surgeries relied on providing local anesthesia and small incision cuts. Further, patients suffering from spine injuries and diseases are predominantly senior or old. Further, such geriatric population is prone to hypertension, diabetes, obesity, and various others. In order to go along with the surgical requirement, doctors prefer to adopt minimally invasive surgery. Moreover, CDC estimates that by 2040, the geriatric population will occupy close to 22% of the entire population demarcation, which for now is close to 16%. Owing to such factors, the market has and will grow at a steadfast pace.
Minimally Invasive Spine Surgery operations can be provided in Ambulatory Surgical Centers which are gaining traction in the developed countries.
Patients
prefer to visit ASCs for all the minimally invasive surgery options, especially
pertaining to orthopedic ailments. It is attributed to the fact that
satisfaction takes a significant boost, as 92% are satisfied when they had
their procedures done in ASCs against 60% who went to get it done in hospitals.
Moreover, patients have provided the primary reason as “low-hospital stay
time”, “better costs”, and “same-day discharge.” Moreover, the geriatric
populations are opting for such centers as the risk of latching on SSIs is far
low in such setups. Lastly, the Biden Administration plans to save close to $22
billion in their American Rescue Plan setting, as the overall cost ramification
is far lower in the following setup.
Minimally Invasive Spine Surgery Market Challenges
The growing insurance costs for minimally invasive elective surgeries poses as a grave market challenge.
The
elective surgeries in the pandemic period halted especially the minimally
invasive surgeries. Owing to such volume impeding in the pipeline, insurers
have started to hike the overall insurance costs. Additionally, only 41% of the
surgeries were performed in the ASCs during the pandemic, of which 73% had to
halt their elective surgeries. Owing to the rising demands, insurance companies
have started hiking the cost plan per person, to distribute the overall impact.
Moreover, during the pandemic, most of the families had to in-cash their
medical insurances, which further made the funds available for the companies go
low. In order to retain the lost capital, costs have zoomed, and have acted as
a grave market challenge.
Minimally Invasive Spine Surgery Industry Outlook
Product launches, mergers and acquisitions, joint ventures,
and geographical expansions are key strategies adopted by players in this market. Minimally
Invasive Spine Surgery top 10 companies include:
- Globus Medical Inc
- NuVasive Inc
- Life Spine In
- Paradigm Spine
- Medtronic
- Johnson & Johnson
- Boston Scientific
- Zimmer Biomet
- Mikai S.p.A,
- Synthes GmbH
Recent Developments
- In November 2021, Max Hospital launched the “Da-Vinci- XI” surgical robot to assist in performing robotic-assisted minimally invasive procedures or surgeries. The device can mimic a surgeon’s hand movement in real-time, at the console whereby bending and rotating the instruments according to the will and need for procedure. Moreover, apart from spine and orthopedic surgeries, it can come in handy for oncology, bariatric surgery procedures, gynaecology, general surgery, and various others.
- In October 2021, Medtronic unveiled three additions to its minimally invasive spine surgery portfolio. It now includes surgical access hardware, expandable titanium interbody implants, and a bone graft delivery system. It would allow for transformational lumbar interbody fusion or TLIF procedure. Moreover, it would allow to treat conditions such as herniated discs or fractured vertebrae.
- In May 2019, Boston Scientific acquired Veriflex. The latter company is known to provide an indirect compression system, a minimally invasive device to alleviate pain pertaining to LSS or Lower Spinal Stenosis. Moreover, the reason for acquisition is to hold on to a dominant position in the pain management portfolio. Lastly, the company wishes to aggressively put its forward in the dimension of treating LSS cases, for which the cases account for 6 million in the US.
Relevant Titles
Orthopedic
Braces & Support, Casting & Splints Market – Forecast (2021 - 2026)
Report Code- HCR 0670
Orthopedic
Devices Market – Forecast (2022 - 2027)
Report
Code- HCR 1228
For more Lifesciences and Healthcare Market reports, please click here
LIST OF TABLES
1.Global Global Lixisenatide Market, By Product Market 2023-2030 ($M)1.1 Industrial Grade Market 2023-2030 ($M) - Global Industry Research
1.2 Pharmaceutical Grade Market 2023-2030 ($M) - Global Industry Research
2.Global Hospital Market 2023-2030 ($M)
3.Global Global Lixisenatide Market, By Product Market 2023-2030 (Volume/Units)
3.1 Industrial Grade Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 Pharmaceutical Grade Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global Hospital Market 2023-2030 (Volume/Units)
5.North America Global Lixisenatide Market, By Product Market 2023-2030 ($M)
5.1 Industrial Grade Market 2023-2030 ($M) - Regional Industry Research
5.2 Pharmaceutical Grade Market 2023-2030 ($M) - Regional Industry Research
6.North America Hospital Market 2023-2030 ($M)
7.South America Global Lixisenatide Market, By Product Market 2023-2030 ($M)
7.1 Industrial Grade Market 2023-2030 ($M) - Regional Industry Research
7.2 Pharmaceutical Grade Market 2023-2030 ($M) - Regional Industry Research
8.South America Hospital Market 2023-2030 ($M)
9.Europe Global Lixisenatide Market, By Product Market 2023-2030 ($M)
9.1 Industrial Grade Market 2023-2030 ($M) - Regional Industry Research
9.2 Pharmaceutical Grade Market 2023-2030 ($M) - Regional Industry Research
10.Europe Hospital Market 2023-2030 ($M)
11.APAC Global Lixisenatide Market, By Product Market 2023-2030 ($M)
11.1 Industrial Grade Market 2023-2030 ($M) - Regional Industry Research
11.2 Pharmaceutical Grade Market 2023-2030 ($M) - Regional Industry Research
12.APAC Hospital Market 2023-2030 ($M)
13.MENA Global Lixisenatide Market, By Product Market 2023-2030 ($M)
13.1 Industrial Grade Market 2023-2030 ($M) - Regional Industry Research
13.2 Pharmaceutical Grade Market 2023-2030 ($M) - Regional Industry Research
14.MENA Hospital Market 2023-2030 ($M)
LIST OF FIGURES
1.US Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)2.Canada Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
3.Mexico Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
4.Brazil Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
5.Argentina Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
6.Peru Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
7.Colombia Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
8.Chile Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
9.Rest of South America Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
10.UK Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
11.Germany Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
12.France Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
13.Italy Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
14.Spain Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
15.Rest of Europe Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
16.China Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
17.India Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
18.Japan Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
19.South Korea Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
20.South Africa Minimally Invasive Spine Surgery Market Revenue, 2023-2030 ($M)
21.North America Minimally Invasive Spine Surgery By Application
22.South America Minimally Invasive Spine Surgery By Application
23.Europe Minimally Invasive Spine Surgery By Application
24.APAC Minimally Invasive Spine Surgery By Application
25.MENA Minimally Invasive Spine Surgery By Application
26.Zealand Pharma A/S, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Sanofi-Aventis Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)